We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.68%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73B
AUM Growth
-$32.7M
(-0.57%)
Cap. Flow
-$304M
Cap. Flow
% of AUM
-5.3%
Top 10 Holdings %
Top 10 Hldgs %
52.96%
Holding
258
New
61
Increased
37
Reduced
51
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$103M |
| 2 |
Amazon
AMZN
|
+$91.5M |
| 3 |
Biogen
BIIB
|
+$49.7M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$49.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$101M |
| 2 |
Ross Stores
ROST
|
+$100M |
| 3 |
Five Below
FIVE
|
+$76.2M |
| 4 |
lululemon athletica
LULU
|
+$76.1M |
| 5 |
Incyte
INCY
|
+$73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.98% |
| 2 | Consumer Staples | 5.76% |
| 3 | Technology | 4.46% |
| 4 | Consumer Discretionary | 4.37% |
| 5 | Communication Services | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLRX
201
BioLineRX
BLRX
$11.8M
| – | – |
-69,926
| Closed | -$2.59M |
|
202
Bristol-Myers Squibb
BMY
$130B
| – | – |
-600,000
| Closed | -$42.7M |
|
203
Benitec Biopharma
BNTC
$436M
| – | – |
-91,473
| Closed | -$578K |
|
204
CrowdStrike
CRWD
$214B
| – | – |
-192,000
| Closed | -$7.91M |
|
205
Dollar Tree
DLTR
$24.7B
| – | – |
-135,535
| Closed | -$18.4M |
|
206
Estee Lauder
EL
$31.5B
| – | – |
-78,000
| Closed | -$16.8M |
|
207
Eterna Therapeutics
ERNA
$4.78M
| – | – |
-148
| Closed | -$274K |
|
208
Elastic
ESTC
$7.25B
| – | – |
-55,000
| Closed | -$3.95M |
|
209
FedEx
FDX
$73.5B
| – | – |
-80,000
| Closed | -$11.9M |
|
|
210
Five Below
FIVE
$12.4B
| – | – |
-553,231
| Closed | -$76.2M |
|
211
Healthcare Triangle
HCTI
$2.19M
| – | – |
-21
| Closed | -$1.14M |
|
|
NBP
212
NovaBridge Biosciences American Depositary Shares
NBP
$190M
| – | – |
-1,768,000
| Closed | -$7.09M |
|
213
Intuit
INTU
$89.7B
| – | – |
-17,000
| Closed | -$6.58M |
|
214
Iveda Solutions
IVDA
$3.41M
| – | – |
-115,658
| Closed | -$601K |
|
215
MongoDB
MDB
$30.3B
| – | – |
-27,000
| Closed | -$5.36M |
|
216
Mondelez International
MDLZ
$79.9B
| – | – |
-571,000
| Closed | -$31.3M |
|
217
MediWound
MDWD
$182M
| – | – |
-273,646
| Closed | -$2.66M |
|
218
Meta Platforms (Facebook)
META
$1.5T
| – | – |
-61,000
| Closed | -$8.28M |
|
|
BGDE
219
Big Digital Energy Inc
BGDE
$33.6M
| – | – |
-32,778
| Closed | -$1.7M |
|
220
monday.com
MNDY
$3.87B
| – | – |
-30,000
| Closed | -$3.4M |
|
221
Netflix
NFLX
$309B
| – | – |
-225,000
| Closed | -$5.3M |
|
222
ServiceNow
NOW
$121B
| – | – |
-85,000
| Closed | -$6.42M |
|
223
Natera
NTRA
$39.3B
| – | – |
-672,000
| Closed | -$29.4M |
|
|
NVVE
224
DELISTED
Nuvve Holding Corp
NVVE
| – | – |
-6
| Closed | -$2.27M |
|
225
Onconetix
ONCO
$3.69M
| – | – |
-5
| Closed | -$1.47M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Armistice Capital held 258 positions worth $5.73B, down 0.57% from $5.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Armistice Capital withdrew a net $304M in Q4 2022, closing 64 positions and reducing 51 holdings. Its most notable exit was Five Below, an estimated $76.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Armistice Capital opened a new position in CVS Health worth $44.4M.
- Armistice Capital's largest Q4 2022 buy was CVS Health: 476,000 shares worth $44.4M.
- Armistice Capital added most to Mirati Therapeutics, Inc. Common Stock in Q4 2022, an estimated $103M increase.
- Armistice Capital's biggest Q4 2022 reduction was Madrigal Pharmaceuticals, cutting an estimated $101M.
- Armistice Capital fully exited Five Below in Q4 2022, selling an estimated $76.2M.
- Armistice Capital's ten largest holdings make up 53% of its $5.73B portfolio in Q4 2022.
- Armistice Capital opened 61 new positions and closed 64 in Q4 2022.
- Armistice Capital's portfolio value fell 0.57% quarter-over-quarter to $5.73B.
Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.